Pancreatic Cancer Research

ResearcherHebei Medical UniversityActive in the last 2 years

Peng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8257-6182; OpenAlex author ID A5100778423. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 3

  1. NCOA6 knockdown enhances RSL3-induced ferroptosis in pancreatic cancer cells and increases the sensitivity to gemcitabine. Last author DOI 10.3724/abbs.2024221↗
  2. Nuclear receptor coactivator 6 (NCoA6) promotes cell proliferation, migration, and invasion in pancreatic cancer. Last author DOI 10.1002/cam4.6427↗
  3. Knockdown of LINC00657 inhibits the viability, migration and invasion of pancreatic cancer cells by regulating the miR-520h/CKS1B axis. Co-author DOI 10.3892/etm.2021.10576↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaowu Xu · 2 shared papers, 2023–2025 · strength 0.41
  2. Xin Wang · 2 shared papers, 2023–2025 · strength 0.41
  3. Yuming Jia · 2 shared papers, 2023–2025 · strength 0.41
  4. Wuhan Yang · 1 shared paper, 2025 · strength 0.24
  5. Ye Zeng · 1 shared paper, 2025 · strength 0.24
  6. Changfeng Song · 1 shared paper, 2023 · strength 0.17
  7. Yi Qin · 1 shared paper, 2023 · strength 0.17
  8. Yue Ma · 1 shared paper, 2021 · strength 0.15
  9. Guangyu Chen · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.